FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2019999154> ?p ?o ?g. }

• W2019999154 endingPage "182" @default.
• W2019999154 startingPage "173" @default.
• W2019999154 abstract "Firstly, to give a review of characteristic indocyanine green angiographic (ICGA) signs in Vogt-Koyanagi-Harada (VKH) disease and, secondly, to determine the utility of ICG angiography in the assessment and follow-up of choroidal inflammatory activity during initial high-dose inflammation suppressive therapy and during the tapering of therapy.We have first reviewed characteristic ICGA signs in VKH. This is followed by a study of four patients with an acute initial VKH uveitis episode who received regular initial and follow-up angiographic examinations for at least 9 months. Classical ICGA signs were recorded at onset and followed for at least 9 months and were correlated with treatment levels. The treatment consisted of high-dose oral corticosteroids (0.8-1.5 mg/kg) preceded by pulse intravenous methylprednisolone (500-1000 mg) for 3 days in hyperacute cases and followed by very slow tapering with the addition of an immunosuppressive agent in cases of insufficient response.The major ICGA signs that were both consistently present and easy to record in the four VKH patients having an acute initial uveitis episode with a pre-treatment angiography and an angiographic follow-up for a minimum of 9 months include (1) early choroidal stromal vessel hyperfluorescence and leakage, (2) hypofluorescent dark dots, (3) fuzzy vascular pattern of large stromal vessels and (4) disc hyperfluorescence. All patients were treated with high-dose inflammation suppressive therapy: in two patients, within 14 and 21 days after initial symptoms, respectively, and in the other two patients, within 6 weeks. Hypofluorescent dark dots, the most constant and easily recordable sign, was very prominent in all cases at presentation. A 90% to complete resolution of dark dots was noted in all four patients after 4 months of therapy. The other three major angiographic signs, early choroidal stromal vessel hyperfluorescence and leakage, indistinct fuzzy vessels at the intermediate angiographic phase and disc hyperfluorescence resolved in all cases within 8 weeks or less of high-dose inflammation suppressive therapy. In three of the four patients, dark dots reappeared after a mean of 7.8 +/- 2.8 months after onset of therapy when the patients were under a mean corticosteroid dose of 13.2 +/- 6.3 mg per day without any significant clinical or fluorescein angiographic signs, indicating subclinical recurrence. An increase in the inflammation suppressive therapy again brought about angiographic resolution of choroidal subclinical disease in all cases.Choroidal inflammation shown by ICG angiography can be suppressed completely by initial high-dose inflammation suppressive therapy. However, recurrent subclinical choroidal inflammation is detected at the end of the tapering period in a high proportion of cases. This indicates that, in the absence of an ICGA follow-up, undetected smoldering subclinical disease may persist, thereby explaining the frequently reported evolution towards sunset glow fundus despite an apparently controlled disease. This is a clear indication that VKH disease should be followed by ICG angiography and, in the case of choroidal subclinical reactivation, a reversal of therapy tapering and an extension of therapy duration should be considered." @default.
• W2019999154 created "2016-06-24" @default.
• W2019999154 creator A5000294188 @default.
• W2019999154 creator A5002948762 @default.
• W2019999154 creator A5071824714 @default.
• W2019999154 date "2007-04-25" @default.
• W2019999154 modified "2023-10-06" @default.
• W2019999154 title "Indocyanine green angiography in Vogt–Koyanagi–Harada disease: angiographic signs and utility in patient follow-up" @default.
• W2019999154 cites W1515045354 @default.
• W2019999154 cites W2005105798 @default.
• W2019999154 cites W2007555400 @default.
• W2019999154 cites W2013052596 @default.
• W2019999154 cites W2013124253 @default.
• W2019999154 cites W2025952767 @default.
• W2019999154 cites W2031134629 @default.
• W2019999154 cites W2041010053 @default.
• W2019999154 cites W2062516208 @default.
• W2019999154 cites W2070703321 @default.
• W2019999154 cites W2075332893 @default.
• W2019999154 cites W2079753882 @default.
• W2019999154 cites W2087994722 @default.
• W2019999154 cites W2092038142 @default.
• W2019999154 cites W2098972002 @default.
• W2019999154 cites W2137027145 @default.
• W2019999154 cites W2159636925 @default.
• W2019999154 cites W2169941091 @default.
• W2019999154 cites W2341329109 @default.
• W2019999154 cites W2368319130 @default.
• W2019999154 cites W2394013404 @default.
• W2019999154 cites W2434370866 @default.
• W2019999154 doi "https://doi.org/10.1007/s10792-007-9060-y" @default.
• W2019999154 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/17457515" @default.
• W2019999154 hasPublicationYear "2007" @default.
• W2019999154 type Work @default.
• W2019999154 sameAs 2019999154 @default.
• W2019999154 citedByCount "131" @default.
• W2019999154 countsByYear W20199991542012 @default.
• W2019999154 countsByYear W20199991542013 @default.
• W2019999154 countsByYear W20199991542014 @default.
• W2019999154 countsByYear W20199991542015 @default.
• W2019999154 countsByYear W20199991542016 @default.
• W2019999154 countsByYear W20199991542017 @default.
• W2019999154 countsByYear W20199991542018 @default.
• W2019999154 countsByYear W20199991542019 @default.
• W2019999154 countsByYear W20199991542020 @default.
• W2019999154 countsByYear W20199991542021 @default.
• W2019999154 countsByYear W20199991542022 @default.
• W2019999154 countsByYear W20199991542023 @default.
• W2019999154 crossrefType "journal-article" @default.
• W2019999154 hasAuthorship W2019999154A5000294188 @default.
• W2019999154 hasAuthorship W2019999154A5002948762 @default.
• W2019999154 hasAuthorship W2019999154A5071824714 @default.
• W2019999154 hasBestOaLocation W20199991542 @default.
• W2019999154 hasConcept C118487528 @default.
• W2019999154 hasConcept C120665830 @default.
• W2019999154 hasConcept C121332964 @default.
• W2019999154 hasConcept C141071460 @default.
• W2019999154 hasConcept C2776194053 @default.
• W2019999154 hasConcept C2776694393 @default.
• W2019999154 hasConcept C2777093970 @default.
• W2019999154 hasConcept C2778257484 @default.
• W2019999154 hasConcept C2778396096 @default.
• W2019999154 hasConcept C2780248432 @default.
• W2019999154 hasConcept C2780372218 @default.
• W2019999154 hasConcept C2780643987 @default.
• W2019999154 hasConcept C2781065829 @default.
• W2019999154 hasConcept C2910234007 @default.
• W2019999154 hasConcept C71924100 @default.
• W2019999154 hasConceptScore W2019999154C118487528 @default.
• W2019999154 hasConceptScore W2019999154C120665830 @default.
• W2019999154 hasConceptScore W2019999154C121332964 @default.
• W2019999154 hasConceptScore W2019999154C141071460 @default.
• W2019999154 hasConceptScore W2019999154C2776194053 @default.
• W2019999154 hasConceptScore W2019999154C2776694393 @default.
• W2019999154 hasConceptScore W2019999154C2777093970 @default.
• W2019999154 hasConceptScore W2019999154C2778257484 @default.
• W2019999154 hasConceptScore W2019999154C2778396096 @default.
• W2019999154 hasConceptScore W2019999154C2780248432 @default.
• W2019999154 hasConceptScore W2019999154C2780372218 @default.
• W2019999154 hasConceptScore W2019999154C2780643987 @default.
• W2019999154 hasConceptScore W2019999154C2781065829 @default.
• W2019999154 hasConceptScore W2019999154C2910234007 @default.
• W2019999154 hasConceptScore W2019999154C71924100 @default.
• W2019999154 hasIssue "2-3" @default.
• W2019999154 hasLocation W20199991541 @default.
• W2019999154 hasLocation W20199991542 @default.
• W2019999154 hasLocation W20199991543 @default.
• W2019999154 hasOpenAccess W2019999154 @default.
• W2019999154 hasPrimaryLocation W20199991541 @default.
• W2019999154 hasRelatedWork W1998302371 @default.
• W2019999154 hasRelatedWork W2012465402 @default.
• W2019999154 hasRelatedWork W2019999154 @default.
• W2019999154 hasRelatedWork W2021773380 @default.
• W2019999154 hasRelatedWork W2051575181 @default.
• W2019999154 hasRelatedWork W2148584887 @default.
• W2019999154 hasRelatedWork W2394013404 @default.
• W2019999154 hasRelatedWork W2886968148 @default.
• W2019999154 hasRelatedWork W3080917019 @default.

• next